Novo Nordisk A/S (NOV.DE)
Makes insulin and weight-loss drugs for diabetes and obesity patients worldwide.
45.08+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+8.2%
The outlook
NOV.DE is trading above both its 50- and 200-day moving averages, positioning it in the middle-to-upper half of its 52-week range. The stock carries a lean-bullish analyst sentiment with a trailing P/E of 12.3, reflecting relatively modest valuation metrics. Today's trading shows minimal movement near current levels.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range60% of the way from its 52-week low to high
Market cap
$199.34B
52-wk high
54.87
52-wk low
30.24
50-day avg
40.71
200-day avg
40.17
Trailing P/E
12.3